View Older Stories View More Recent Stories
-
Air New Zealand warns of tough year ahead after profit drop, shares fall
-
Repare Therapeutics Announces Strategic Reprioritization to Focus on Broad Clinical Portfolio
-
More Canadian Companies Reskilling Existing Employees Rather than Hiring New Due to Budget Constraints
-
Senator Marco Rubio calls out Deere for layoffs, Mexico shift
-
Exclusive-Intel board member quit after differences over chipmaker's revival plan
-
Clearside Biomedical Announces Completion of Final Participant Visit in ODYSSEY Phase 2b Trial of CLS-AX in Wet AMD
-
Job concerns weigh on German consumer sentiment in September, finds GfK
-
With Fed's shift to job market risks done, policy now has to catch up
-
Powell green lights September rate cut
-
Piper Sandler Assumes Etsy (ETSY) at Neutral
-
Canada's rail shutdown could hit GDP hard, kill jobs if protracted
-
Enserva Condemns Ongoing Rail Labour Dispute, Warns of Immediate Economic and Social Fallout
-
US business activity edges lower; pricing power ebbs further
-
July minutes highlighted labor market risk: Analysts
-
Nano One Streamlines Operations to Enhance Focus on LFP and Commercialization
-
Bank of Queensland to cut about 400 jobs in restructuring drive
-
Zuora Reports Second Quarter Fiscal 2025 Results
-
Musk's ban on remote work at X beats disability bias claim for now
-
Germany's Scholz to visit shipbuilder amid state aid hopes
-
Five9, Inc (FIVN) PT Lowered to $45 at Rosenblatt
-
Peloton's earnings to draw focus on CEO search, efforts to grow subscribers
-
Ultimovacs ASA Reports Second Quarter 2024 Financial Results and Provides General Business Update
-
Aadi Bioscience (AADI) Provides PRECISION1 Trial and Corporate Updates
-
Aadi Bioscience Provides PRECISION1 Trial and Corporate Updates
-
Rule 2.7 Announcement: Gran Tierra Energy to Acquire i3 Energy plc
-
GS analysis: Earnings results suggest consumer slowdown concerns overstated
-
Kineta Reopens Enrollment for the VISTA-101 Clinical Trial Evaluating KVA12123 in Patients with Advanced Solid Tumor Cancer
-
GM lays off over 1,000 salaried software, services employees
-
Estee Lauder forecasts bleak annual results; CEO Freda to depart
-
Porsche agrees to provide capital in Varta restructuring deal
-
Consumer Staying Power May Come Down to Credit
-
Tempur Sealy's deal to buy Mattress Firm aims to 'eliminate' competition, document shows
-
Cisco Systems (CSCO) lifted to Buy at HSBC and New Street Research
-
Fed likely to cut but not rush: BofA
-
Barclays warns of Japan-style recession risk for China
-
Whitehaven Coal to cut 192 jobs at mines purchased from BHP
-
Midday movers: Walmart, Cisco, Deere, Ulta Beauty rise; Alibaba falls
-
We Work For Health Statement on IRA Medicare Price Setting Announcement
-
CureVac Announces Financial Results for the Second Quarter and First Half of 2024 and Provides Business Update
-
Viracta Therapeutics (VIRX) PT Lowered to $4 at RBC Capital
-
US economic data, Cisco, Walmart, UK growth - what's moving markets
-
SoftBank scraps AI chips tie-up plan with Intel, FT reports
-
Cisco shares surge on earnings beat and job cuts
-
Phio Pharmaceuticals Reports Second Quarter 2024 Financial Results and Provides Business Update
-
Dow declares quarterly dividend of 70 cents per share
-
StoneCo Reports Second Quarter 2024 Results
-
GEE Group Announces Results for the Fiscal 2024 Third Quarter and YTD
-
Swedish EV maker Polestar starts U.S. production, avoiding heavy tariffs
-
Galera Therapeutics (GRTX) Announces Board Approval of Complete Liquidation and Dissolution
-
Vicinity Motor (VEV) Applies for Management Cease Trade Order
